Enterolactone combined with m6A Reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer.
Xu M, Guo Y, Wang F, Lin C, Cao D, Yan Y, Chai S, Zhao Y, Deng S, Wei J, Kang X, Liu Y, Zhang Y, Luo L, Liu SL, Liu H.
Xu M, et al. Among authors: wang f.
Phytomedicine. 2024 Dec 21;136:156343. doi: 10.1016/j.phymed.2024.156343. Online ahead of print.
Phytomedicine. 2024.
PMID: 39765033